Mounier, M; Bossard, N; Remontet, L; Belot, A; Minicozzi, P; de Angelis, R; Capocaccia, R; Iwaz, J; Monnereau, A; Troussard, X; +5 more... Sant, M; Maynadie, M; Giorgi, R; Grp, E.-, W; Grp, CWS; (2015) Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5). Lancet Haematology, 2 (11). E481-E491. ISSN 2352-3026 DOI: https://doi.org/10.1016/s2352-3026(15)00155-6 Full text not available from this repository.

Bligh, J; Schramm, G; Chiodini, PL; Doenhoff, MJ; (2010) Serological analysis of the outcome of treatment of Schistosoma mansoni infections with praziquantel. Annals of tropical medicine and parasitology, 104 (6). pp. 511-520. ISSN 0003-4983 DOI: https://doi.org/10.1179/136485910X12786389891245 Full text not available from this repository.

Luna, KP; Hernandez, IP; Rueda, CM; Zorro, MM; Croft, SL; Escobar, P; (2009) In vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole. Biomedica, 29 (3). pp. 448-455. ISSN 0120-4157 https://researchonline.lshtm.ac.uk/id/eprint/4496 Full text not available from this repository.

Coro, J; Little, S; Yardley, V; Suarez, M; Rodriguez, H; Martin, N; Perez-Pineiro, R; (2008) Synthesis and Antiprotozoal Evaluation of New N-4-(Benzyl)spermidyl-linked bis(1,3,5-thiadiazinane-2-thiones). Archiv der Pharmazie, 341 (11). pp. 708-713. ISSN 0365-6233 DOI: https://doi.org/10.1002/ardp.200800011 Full text not available from this repository.

Prathalingham, SR; Wilkinson, SR; Horn, D; Kelly, JM; (2007) Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole. Antimicrobial agents and chemotherapy, 51 (2). pp. 755-758. ISSN 0066-4804 DOI: https://doi.org/10.1128/aac.01360-06 Full text not available from this repository.

Rijal, S; Yardley, V; Chappuis, F; Decuypere, S; Khanal, B; Singh, R; Boelaert, M; de Doncker, S; Croft, S; Dujardin, JC; (2007) Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes and infection / Institut Pasteur, 9 (4). pp. 529-535. ISSN 1286-4579 DOI: https://doi.org/10.1016/j.micinf.2007.01.009 Full text not available from this repository.

Hotez, PJ; Arora, S; Bethony, J; Bottazzi, ME; Loukas, A; Correa-Oliveira, R; Brooker, S; (2005) Helminth infections of children: Prospects for control. [Conference or Workshop Item] https://doi.org/10.1007/0-387-25342-4_9 Full text not available from this repository.